Antidiabetics Market 2018 – 2024 Global Key Leaders: Novartis AG, Sanofi, Bayer Corporation, Boehringer Ingelheim, Eli Lilly, Johnson & Johnson, Merck, Novo Nordisk, Pfizer
Germany antidiabetics industry accounted for largest revenue size of USD 4,461.7 million of Europe antidiabetics industry in 2017. According to WHO, in 2016, it was estimated that 22.7% people in Germany are suffering from obesity which is the major risk factor associated with diabetes. Mortality rate due to diabetes is also increasing at fast pace. Moreover, availability of medicines, technologies and facilities for the disease treatment will stimulate German antidiabetics market growth.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467744/
Growing incidence coupled with increasing risk of diabetes will augment antidiabetics market growth over the coming years. Excess weight significantly escalates risk of type 2 diabetes mellitus (T2DM). Also, the risk of developing diabetes by 25 years of age increases four times in obese children. Thus, rising incidence of diabetes will result into substantial rise in demand for antidiabetics, thereby impelling antidiabetics business growth. Antidiabetics Market will reach over USD 110 billion by 2024; as per a new research report.
With accelerating growth in number of diabetes cases, prominent players are concentrating their efforts on developing newer and improved antidiabetic drugs. Many leading players including Sanofi, Novo Nordisk and Eli Lilly have a broad pipeline portfolio of antidiabetic drugs that aim to diversify the set of therapeutic alternatives for diabetes patients. Thus, growing R&D activities should positively impact antidiabetics industry growth in forthcoming timeframe.
Insulin product segment is estimated to witness 12.3% CAGR during the forecast period. High revenue share is attributable to widening use of insulin therapy for the treatment of type 2 diabetes. Besides, insulin is available in several forms depending upon its rate of action. In addition, insulin therapy decreases microvascular complications that should boost adoption rate of insulin in the upcoming years.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467744/
Geriatric patient population segment accounted for nearly 42.2% market share in 2017 and is estimated to follow similar trend during the forecast timeline. T2DM is an emerging problem in elderly population. As per American Diabetes Association, about 25% of Americans aged above 60 years of age suffer from diabetes. The risk in treating diabetes through changes in dietary habits is further elevated due to impaired physical functioning. Such factors coupled with rising awareness to educate older population about reducing risk of diabetes will act as high impacting factor for geriatric segment growth.
Oral route of administration segment accounted for 72.6% market share in 2017 and will grow at a significant pace during the forecast timeframe due to effectivity and efficacy of treatment coupled with convenience. A study conducted by International Journal of Pharmaceutical Research indicated that oral antidiabetics are most frequently prescribed hypoglycemics. Above factors will highly contribute to segmental growth in projected period.
India antidiabetics market is estimated to progress at 14.3% CAGR during the forecast timeframe. Growing adoption of binge eating habits as well as accelerating elderly population will considerably contribute to increase in Indian antidiabetics market. Additionally, firms are undertaking organic growth initiatives to expand in Indian market. For instance, Lupin and Boehringer Ingelheim collaborated for co-marketing its oral antidiabetics across India, that should offer lucrative market growth potential in forthcoming years.
Some of the major market players involved in global antidiabetics market are Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, and Sanofi. Companies are focusing on partnerships and novel product launch to expand their market presence and enhance customer portfolio.
Table of Content:
Chapter 1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
18.104.22.168. Paid sources
22.214.171.124. Unpaid sources
Chapter 2. Executive Summary
2.1. Antidiabetics industry 360 degree synopsis, 2013 - 2024 (USD Million)
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Patient population trends
2.1.4. Route of administration trends
2.1.5. Regional trends
Chapter 3. Antidiabetics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
126.96.36.199. Strong product pipeline of antidiabetics
188.8.131.52. Globally rising prevalence of diabetes
184.108.40.206. Increasing prevalence of lifestyle induced disorders such as obesity
3.3.2. Industry pitfalls and challenges
220.127.116.11. Prohibitive cost of insulin
3.4. Regulatory landscape
3.5. Clinical workflow analysis
3.6. Reimbursement scenario
3.7. Growth potential analysis
3.7.1. By product
3.7.2. By patient population
3.7.3. By route of administration
3.8. Porter's analysis
3.9. Competitive landscape
3.9.1. Company market share analysis, 2017
3.9.2. Strategy dashboard
3.10. PESTEL analysis
3.11. Pipeline overview, 2018
Chapter 4. Antidiabetics Market, By Product
4.1. Key segment trends
4.2.1. Market size, by region, 2013-2024 (USD Million)
For more information on this report at: https://www.marketstudyreport.com/reports/antidiabetics-market/?utm_source=Openpr.com-SP
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Antidiabetics Market 2018, Forecast to 2023
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antidiabetics Market 2018 – 2024 Global Key Leaders: Novartis AG, Sanofi, Bayer Corporation, Boehringer Ingelheim, Eli Lilly, Johnson & Johnson, Merck, Novo Nordisk, Pfizer here
News-ID: 1511529 • Views: 247
More Releases from marketstudyreport.com
Clinical Laboratory Services Market By Regional Trend & Growth Forecast 2019-202 …
Market Study Report recently introduced new title on “Global Carbon Black Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2025. The Latin America breast pump market accounted for more than 12% revenue share in 2018 and is assessed to witness a significant CAGR by 2025. This is due to the development in healthcare facilities
Sleep Apnea Devices Market - Growth, Trends, and Forecast (2019 - 2025)
Market Study Report recently introduced new title on “2019-2025 Global Sleep Apnea Devices Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates market outlook and status to 2025. Technological advancements in sleep apnea devices is a major market growth augmenting factor. Hypoglossal Nerve Stimulation (HNS), is a completely novel approach for treating obstructive sleep apnea. Moreover, growing alcohol intake in
What's driving the Structural Steel Market trends? ArcelorMittal, Tata Steel, Ni …
A detailed study on ‘Structural Steel market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
What's driving the Industrial IoT (IIoT) Market trends? Rockwell Automation, ABB …
A detailed study on ‘Industrial IoT (IIoT) Market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors
More Releases for Antidiabetics
US Antidiabetics Drug Market Outlook 2022 Report
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects Download Report Sample Weblink: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php For Report Sample Contact: email@example.com Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin
US Antidiabetics Drug Market Outlook 2022 Report Download
“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the diabetes epidemiology (Prevalence of Type 1 and 2 Diabetes) in the US market along with the associated economic burden and productivity loss. “US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs
Antidiabetics Market Intelligence with Competitive Landscape 2023
The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. The anti-diabetics market
Global Antidiabetics Drug Market Size - Industry Analysis And Forecast
Latest industry research report on: Global Antidiabetics Drug Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antidiabetics Drug in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1270897 Global Antidiabetics Drug market competition by top manufacturers, with production, price, revenue
US Antidiabetics Drug Market US Antidiabetics Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin 2.2 Historical En Route towards Oral Diabetic Medication Treatments Available for Diabetes Mellitus 3.1 Non-Pharmacological Approaches for Diabetes Mellitus 3.2 Pharmacological Approaches for Diabetes Mellitus Cataloguing of Antidiabetic Agents 4.1
US To Dominate Global Antidiabetics Drug Market
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects For Report Sample Contact: email@example.com or +91-11-47067990 Download Report: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin